<?xml version="1.0"?>
<Articles JournalTitle="Acta Medica Iranica">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of Antibody and Cytokines Responses in Intranasally and Intramuscularly Administrated BALB/C Mice With Influenza Virus-Like Particle</title>
    <FirstPage>604</FirstPage>
    <LastPage>611</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Haideh</FirstName>
        <LastName>Nadmdari</LastName>
        <affiliation locale="en_US">Department of Immunology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Keshavarz</LastName>
        <affiliation locale="en_US">Department of Medical Virology, School of Medicine, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Talat</FirstName>
        <LastName>Mokhtari-Azad</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, National Influenza Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Farhad</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Department of Virology, School of Public Health, National Influenza Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>12</Month>
        <Day>17</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>04</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We previously developed an influenza virus like particle with HA, M, and NA proteins using Bac-to-Bac expression system and SF9 cell line. To evaluate the immunogenicity of our construct, we assessed the humoral, cytokine induced by H1N1-VLP in BALB/c mice immunized intranasally and intramuscularly. Enzyme-linked immunosorbent assay and Relative quantitative real-time PCR were used to evaluate the antibody (IgG and IgA) and mRNA levels of IL-6, IL-4, IL-10 and IFN-g in PBMCs. Our results showed that VLP was capable of intranasal (I.N.) and intramuscular (I.M.) induction of serum IgG and IgA responses. Interestingly, I.N. route induced higher IgG and IgA titer than I.M. route, which was statistically significant. Moreover, mRNA levels of IL-6 (4.2-4.5 folds), IFN-g (5.5-5.7 folds), and the anti-inflammatory cytokine IL-10 (2.5-3 folds) and IL-4 (2.4-2.8 folds) were significantly elevated in mice immunized I.N. and I.M. with H1N1-VLP compared to the control group. Our findings indicated that a non-infectious genome-less VLP approach mimics parenteral virus with multiple viral antigens and epitopes that stimulate a diverse set of immune responses such as innate immunity, specific serum IgG antibody, cell-mediated immunity, and local antibodies.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6069</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6069/4997</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Kleefstra Syndrome: The First Case Report From Iran</title>
    <FirstPage>650</FirstPage>
    <LastPage>654</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Mehrdad</FirstName>
        <LastName>Noruzinia</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad</FirstName>
        <LastName>Ahmadvand</LastName>
        <affiliation locale="en_US">Hematology, Oncology and Stem Cell Transplantation Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Oranous</FirstName>
        <LastName>Bashti</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ahmad Reza</FirstName>
        <LastName>Salehi Chaleshtori</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medical Sciences, Tarbiat Modares University, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>05</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>08</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Kleefstra Syndrome is characterized by severe mental retardation, brachycephaly, microcephaly, epileptic seizures, distinct facial features, and infantile weak muscle tone and heart defects. Deletion of EHMT1 is the main player in 75% of cases. Because of blurriness in genotype-phenotype correlation through clinical and molecular features of both 9q34.3 microdeletion patients and those with an intragenic EHMT1 mutation in Kleefstra Syndrome, genetic characterization of patients with clinical symptoms of such spectrum is desirable. We report the first Kleefstra Syndrome patient in Iran characterized through genetic approaches. Our report could improve KS diagnosis in Iran and prepare PND and PGs options for involved families.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5676</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5676/5003</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Role of PIEZO2 in Human Mechanosensation</title>
    <FirstPage>664</FirstPage>
    <LastPage>664</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amene</FirstName>
        <LastName>Saghazadeh</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Children&#x2019;s Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Systematic Review and Meta-Analysis Expert Group (SRMEG), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>12</Month>
        <Day>19</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>04</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">No Abstract
&#xD;

&#xA0;</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6074</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6074/5006</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Sleep Apnea and Idiopathic Leg Edema: A Case Control Study</title>
    <FirstPage>612</FirstPage>
    <LastPage>615</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Reza</FirstName>
        <LastName>Shahmirzai</LastName>
        <affiliation locale="en_US">Department of Cardiology, Arak University of Medical Sciences, Arak, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammadreza</FirstName>
        <LastName>Firouzifar</LastName>
        <affiliation locale="en_US">Department of Otorhinolaryngology, Otorhinolaryngology Research Center, Amir A&#x2019;alam Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>10</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>04</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Idiopathic leg edema is subject to a lot of debates among physicians. Recently sleep apnea was stated to be the cause. We sought to investigate this matter in a sample of Iranian patients with idiopathic leg edema. In this case-control study, 110 patients were selected based on our inclusion/exclusion criteria and allocated to the case (with idiopathic edema, n=55) and control (without edema, n=55) groups. Sex, age, weight, height, and body mass index (BMI) of all subjects were recorded. We evaluated daytime somnolence of all patients using Epworth sleepiness scale and then calculated Apnea, hypopnea index (AHI) using ResMed ApneaLink and AHI&#x2265;15 were considered as sleep apnea. Age and sex of both groups were not significantly different. Cases had higher BMI than control groups (P=0.03), but they were not significantly different for obesity (P=0.197). AHI was significantly higher in cases (17.85&#xB1;24.31 vs. 9&#xB1;7.37 P=0.012). Daytime somnolence (cases 8.18&#xB1;5.3 vs. controls 6.5&#xB1;3.3) was also higher in cases. Overall Odds ratio of leg edema and sleep apnea was 3.068 (P=0.025), but it wasn&#x2019;t significant in the two genders. Idiopathic bilateral leg edema is strongly associated with sleep apnea. Routine sleep apnea assessment in patients with idiopathic bilateral leg edema is recommended for both genders.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5935</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5935/4998</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Pericentric Inversion of Chromosome 9 in an Infant With Ambiguous Genitalia</title>
    <FirstPage>655</FirstPage>
    <LastPage>657</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Arya</FirstName>
        <LastName>Sotoudeh</LastName>
        <affiliation locale="en_US">Growth and Development Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Pediatric Endocrinology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Parastoo</FirstName>
        <LastName>Rostami</LastName>
        <affiliation locale="en_US">Growth and Development Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Pediatric Endocrinology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Maryam</FirstName>
        <LastName>Nakhaeimoghadam</LastName>
        <affiliation locale="en_US">Growth and Development Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Pediatric Endocrinology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Reihaneh</FirstName>
        <LastName>Mohsenipour</LastName>
        <affiliation locale="en_US">Growth and Development Research Center, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Pediatric Endocrinology, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nima</FirstName>
        <LastName>Rezaei</LastName>
        <affiliation locale="en_US">Research Center for Immunodeficiencies, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. AND Department of Immunology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. AND Network of Immunity in Infection, Malignancy and Autoimmunity (NIIMA), Universal Scientific Education and Research Network (USERN), Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>06</Month>
        <Day>11</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>04</Month>
        <Day>10</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Pericentric inversion of Chromosome 9 is one of the most common chromosomal abnormalities, which could be associated with various manifestations in some cases. Herein, a patient is presented with ambiguous genitalia that karyotyping revealed pericentric inversion of Chromosome 9 (p12,q13). Pericentric inversion of Chromosome 9 could be considered in the list of differential diagnosis of those with ambiguous genitalia, while chromosomal karyotype and culture could be recommended in children with ambiguous genitalia.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5693</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5693/5004</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Study of Serum Malondialdehyde Level in Opioid and Methamphetamine Dependent Patients</title>
    <FirstPage>616</FirstPage>
    <LastPage>620</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Khadije</FirstName>
        <LastName>Najafi</LastName>
        <affiliation locale="en_US">Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Sajad</FirstName>
        <LastName>Ahmadi</LastName>
        <affiliation locale="en_US">Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mahdi</FirstName>
        <LastName>Rahpeyma</LastName>
        <affiliation locale="en_US">Student Research Committee, School of Pharmacy, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Habibolah</FirstName>
        <LastName>Khazaie</LastName>
        <affiliation locale="en_US">Sleep Disorders Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Asad</FirstName>
        <LastName>Vaisi-Raygani</LastName>
        <affiliation locale="en_US">Department of Biochemistry, School of Medicine, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Moini</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Imam Reza Hospital, Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Amir</FirstName>
        <LastName>Kiani</LastName>
        <affiliation locale="en_US">Regenerative Medicine Research Center (RMRC), Kermanshah University of Medical Sciences, Kermanshah, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>21</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>05</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Opioid compound and methamphetamine are commonly used in drug abuse; these can disrupt the normal function of cellular and molecular systems, leading to several events such as oxidative stress, aging, apoptosis, and necrosis. Malondialdehyde (MDA) is the most important biomarker for evaluation of oxidative stress and determination of lipid peroxidation. In this study, 42 drug abusers and 22 healthy persons participated as case and control groups, respectively. MDA in volunteer sera was determined by high-performance liquid chromatography (HPLC) with &#xFB02;uorescence detection after pre-column derivatization using thiobarbituric acid. The analysis was performed on a ODS column by spectrofluorometer detection, operated at excitation of 515 nm and emission of 535 nm. A mixture of phosphate buffer (0.05 M, pH 6.8), containing potassium monobasic phosphate and methanol (60:40, v/v) at a &#xFB02;ow rate of 1 ml/min, was used as the mobile phase. The retention time of MDA-TBA was 3.2 min. Our findings showed that the MDA level increased in the opioid and methamphetamine abusers when compared to the control group (P&lt;0.05); however, no significant difference was observed between the opioid and methamphetamine groups. A state of oxidative stress during biological processes leads to lipid peroxidation, DNA damage, biomolecule dysfunctions, and many other diseases. Since it is impossible to eradicate the drug addiction, we should reduce the side effects of drug abuse, such as oxidative stress, by intake of proper nutrition and antioxidants.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6250</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6250/4999</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Denosumab Treatment of Severe Disuse Osteoporosis in a Boy With Spinal Muscular Atrophy</title>
    <FirstPage>658</FirstPage>
    <LastPage>660</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Stepan</FirstName>
        <LastName>Kutilek</LastName>
        <affiliation locale="en_US">Department of Pediatrics, Pardubice Hospital, Pardubice, Czech Republic.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>06</Month>
        <Day>23</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>03</Month>
        <Day>21</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Denosumab is a fully human recombinant monoclonal antibody to the receptor activator of nuclear factor-&#x3BA;B ligand. Denosumab is used in the treatment of postmenopausal osteoporosis and cancer-related bone disorders. There are only very scarce data on denosumab treatment in children. 14-year-old boy with spinal muscular atrophy (SMA) and severe disuse osteoporosis (spinal bone mineral density L1-L4 BMD-6.2SD Z-score) and two prevalent fragility fractures was treated with denosumab. He received 60 mg&#xA0; subcutaneous injection at the baseline and seven months later. Six months after the initial injection there was a 19% increase in L1-L4 BMD. The injections were well tolerated without any adverse reactions. Calcemia remained stable (2.3-2.4 mmol/L). He was scheduled for the third denosumab injection six months later. Prior to this date, he acquired pneumonia and died due to respiratory failure, which is a frequent cause of death in patients with SMA. There was no relation to the denosumab treatment. In conclusion, one dose of denosumab significantly increased BMD in a child with severe osteoporosis.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5707</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5707/5008</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>10</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>02</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">A Case With Short Stature, Growth Hormone Deficiency and 46, XX, Xq27-qter Deletion</title>
    <FirstPage>661</FirstPage>
    <LastPage>663</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>&#x15E;ule</FirstName>
        <LastName>Y&#x131;ld&#x131;r&#x131;m</LastName>
        <affiliation locale="en_US">Department of Pediatrics, School of Medicine, &#xC7;anakkale Onsekiz Mart University, &#xC7;anakkale, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Naci</FirstName>
        <LastName>Topalo&#x11F;lu</LastName>
        <affiliation locale="en_US">Department of Pediatrics, School of Medicine, &#xC7;anakkale Onsekiz Mart University, &#xC7;anakkale, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Mustafa</FirstName>
        <LastName>Tekin</LastName>
        <affiliation locale="en_US">Department of Pediatrics, School of Medicine, &#xC7;anakkale Onsekiz Mart University, &#xC7;anakkale, Turkey.</affiliation>
      </Author>
      <Author>
        <FirstName>Fatma</FirstName>
        <LastName>S&#x131;lan</LastName>
        <affiliation locale="en_US">Department of Medical Genetics, School of Medicine, &#xC7;anakkale Onsekiz Mart University, &#xC7;anakkale, Turkey.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>09</Month>
        <Day>16</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>09</Month>
        <Day>24</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">We report a case of 11-year-old girl with growth retardation and 46, XX, Xq27-qter deletion. The endocrinologic evaluation revealed growth hormone deficiency. an University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Moloud</FirstName>
        <LastName>Payab</LastName>
        <affiliation locale="en_US">Obesity and Eating Habits Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Pourmand</LastName>
        <affiliation locale="en_US">Urology Research Center, Sina Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>03</Month>
        <Day>13</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>03</Month>
        <Day>15</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Stress urinary incontinence is a common medical problem among women. The urethral closure complex and/or the supportive mechanisms are responsible for incontinence in the majority of patients. Several surgical procedures with different degrees of invasiveness and outcomes have been reported to treat the problem. Although most of these procedures are reasonably effective, a general trend towards the study of natural and biocompatible tissues is emerging over popular synthetic materials. Here we report our experience of autologous adipose-derived stem cells transplantation into the periurethral region as a new method of stress urinary incontinence treatment. Ten women with symptoms of stress urinary incontinence were treated by injections of autologous adipose-derived stem cells into the periurethral region via transurethral and transvaginal approach under urethroscopic observation. This report presents the short-term outcome of the patients. The outcome measured by pad test results, ICIQ-SF scores, and Qmax. The mean age of the participants was 45.8&#xB1;8.7 years. Urinary incontinence significantly decreased through the first two, 6 and 24 weeks after the injection therapy. The difference was significant in pad test results (P&lt;0.001) and ICIQ-SF scores (P&lt;0.001), especially comparing results between 2 and 6 weeks and among 6 and 24 weeks, but not for 2 and 6 weeks compared to each other. Surprisingly, Qmax showed improvement after the study period (means 32.6 vs. 35.7; P=0.002). This study showed that injection of the autologous adipose-derived stem cells to the periurethral region is a safe, yet short-term effective treatment option for stress urinary incontinence. Further studies with longer follow up are needed to confirm its long term efficacy.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6295</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6295/4947</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">An Uncommon Complication of Streptokinase: Large Spontaneous Iliopsoas Hematoma</title>
    <FirstPage>411</FirstPage>
    <LastPage>413</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Raheleh</FirstName>
        <LastName>Aliabadi</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hassan</FirstName>
        <LastName>Riahi Beni</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jila</FirstName>
        <LastName>Nadjafi</LastName>
        <affiliation locale="en_US">East Surrey Associate Hospital for Brighton University, London, Uk.</affiliation>
      </Author>
      <Author>
        <FirstName>Morteza</FirstName>
        <LastName>Hassanzade</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehrnaz</FirstName>
        <LastName>Tabrizi</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohsen</FirstName>
        <LastName>Nasiri</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Gandom</FirstName>
        <LastName>Sedehi</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Ali</FirstName>
        <LastName>Pourmojarab</LastName>
        <affiliation locale="en_US">Rasoul-e-Akram General Hospital, Iran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2015</Year>
        <Month>10</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2016</Year>
        <Month>04</Month>
        <Day>17</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Streptokinase is a fibrinolytic agent that enhances plasmin activation and is used in selected patients with acute ST elevation myocardial infarction (STEMI). Similar to the other thrombolytics, a common side effect is bleeding, especially from venous puncture sites. Here, we present a case of acute anterior wall STEMI complicated by large spontaneous iliopsoas hematoma after streptokinase administration. With conservative management, the course of the disease was uneventful, and the patient was discharged with no symptom and no clinically important sequel.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5087</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5087/4955</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Assessment of the Prevalence and Risk Factors Associated With Glucocorticoid-Induced Diabetes Mellitus in Pemphigus Vulgaris Patients</title>
    <FirstPage>375</FirstPage>
    <LastPage>380</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Abbas</FirstName>
        <LastName>Darjani</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Nickhah</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Hedayati Emami</LastName>
        <affiliation locale="en_US">Department of Internal Medicine, Endocrinology and Metabolism Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Narges</FirstName>
        <LastName>Alizadeh</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Rana</FirstName>
        <LastName>Rafiei</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Hojat</FirstName>
        <LastName>Eftekhari</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Kaveh</FirstName>
        <LastName>Gharaei Nejad</LastName>
        <affiliation locale="en_US">Department of Dermatology, Skin Research Center, Guilan University of Medical Sciences, Rasht, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2016</Year>
        <Month>04</Month>
        <Day>07</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>01</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Pemphigus vulgaris is a chronic autoimmune disease and glucocorticoids are one of the main treatments. Our study investigates the prevalence and associated factors of glucocorticoid-induced diabetes mellitus in these patients under different glucocorticoid regimens. 36 patients with first diagnosed Pemphigus vulgaris based on pathological and direct immunofluorescence findings who had received different glucocorticoid regimens (1-2 mg/kg oral or 1-2 mg/kg oral with 1g methylprednisolone pulse daily for 3 consecutive days with or without azathioprine) were evaluated during 2014-2016. Our study found that 22.2% of patients had impaired fasting glucose and incidence of corticosteroid-induced diabetes mellitus was 22.2% with no difference between oral and pulse therapy of corticosteroid. The first day after pulse therapy 19 patients of 21 had post bolus hyperglycemia that 36% of them became diabetic after 8 weeks. None of the variables, including age, BMI, HbA1c, LDL, HDL, TG, cholesterol, family history and blood pressure were associated with diabetes. Pretreatment FBS was the factor that would increase the likelihood of glucocorticoid-induced diabetes mellitus, 42.2% of patients with pretreatment FBS 100-126 developed diabetes in comparison with 17.2% in normal pretreatment FBS. Although the group who received azathioprine was associated with increased incidence of diabetes, the overall corticosteroid dose in this group was significantly higher than the other group (P=0.012), and controversy with other studies could be because of difference in corticosteroid dosage and small number of patients. The incidence of diabetes was not different between the group with glucocorticoid pulses and oral prednisolone without pulse therapy. Higher pretreatment FBS can be related to increased incidence of diabetes, but results from this study due to small number of patients are preliminary and multicenter studies are needed.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/5561</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/5561/4948</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Evaluation of Cognitive Functions in Iranian Children and Adolescents With Diabetes Mellitus</title>
    <FirstPage>381</FirstPage>
    <LastPage>388</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Ata</FirstName>
        <LastName>Pourabbasi</LastName>
        <affiliation locale="en_US">Diabetes Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mehdi</FirstName>
        <LastName>Tehrani-Doost</LastName>
        <affiliation locale="en_US">Department of Psychiatry, Rouzbeh Hospital, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Soqra</FirstName>
        <LastName>Ebrahimi Qavam</LastName>
        <affiliation locale="en_US">Department of Educational Psychology, Faculty of Psychology and Education, Allameh Tabataba&#x2019;ee University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Jalal</FirstName>
        <LastName>Farzami</LastName>
        <affiliation locale="en_US">Department of Biostatistics, Faculty of Medical Sciences, Tarbiat Modarres University, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Bagher</FirstName>
        <LastName>Larijani</LastName>
        <affiliation locale="en_US">Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>01</Month>
        <Day>31</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2017</Year>
        <Month>02</Month>
        <Day>07</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Diabetes in children and adolescents is a chronic condition with an expanding trend in the community. Several studies have shown cognitive dysfunctions are the most important side effects of diabetes among individuals of younger ages. Due to cultural differences and their impact on cognitive issues, the authors decided to assess the cognitive functions of Iranian children and adolescents with diabetes. Cognitive functions including memory, attention and executive functions were evaluated in 62 diabetic children and adolescents and healthy peers using CANTAB cognitive tests. Other data such as demographic, school performance and medical information were collected by questionnaires. Except in the case of few variables in RVP, SSP and SST, no significant difference exists between diabetic children and the control group in terms of different cognitive domains. But cognitive variables, especially in PRM, SWM and SOC test, has been shown to be deteriorated with increasing HbA1C values in serum levels. Diabetes has no impact on the cognitive functioning of children provided by maintaining a glycemic control. It is proposed that the adoption of appropriate parenting styles and family and social support can prevent cognitive changes in children with diabetes.</abstract>
    <web_url>https://acta.tums.ac.ir/index.php/acta/article/view/6197</web_url>
    <pdf_url>https://acta.tums.ac.ir/index.php/acta/article/download/6197/4949</pdf_url>
  </Article>
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Acta Medica Iranica</JournalTitle>
      <Issn>0044-6025</Issn>
      <Volume>55</Volume>
      <Issue>6</Issue>
      <PubDate PubStatus="epublish">
        <Year>2017</Year>
        <Month>08</Month>
        <Day>19</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">Smoking Discriminately Changes the Serum Active and Non-Active Forms of Vitamin B12</title>
    <FirstPage>389</FirstPage>
    <LastPage>394</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Niloofar</FirstName>
        <LastName>Shekoohi</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affiliation>
      </Author>
      <Author>
        <FirstName>Mohammad Hassan</FirstName>
        <LastName>Javanbakht</LastName>
        <affiliation locale="en_US">Department of Cellular and Molecular Nutrition, School of Nutritional Sciences and Dietetics, Tehran University of Medical Sciences, Tehran, Iran.</affili